Curate Biosciences

5:15 PM - 5:30 PM (EDT), Monday, June 5, 2023 ・ Session Room 104A
Curate Biosciences is a life science company offering what standard cell processing technologies have failed to provide: the best quality starting material to dramatically reduce the total vein-to-vein cost. The Curate® Cell Processing System allows a faster path to cleaner and larger quantities of starting cells, one of the significant bottlenecks in gene and cell therapies. The Curate® Cell Processing System gently isolates leukocytes using Deterministic Cell Separation™ (DCS), the world's fastest microfluidic technology, which gently separates cells based on size. Optimized for processing apheresis and cell culture samples, the Curate platform obtains larger quantities of healthier leukocytes compared to other separation technologies.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Tools/Drug Development Support Tech
Lead Product in Development:
Curate Cell Processing System
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Curate Biosciences